Literature DB >> 21837623

Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.

Frank Bretz1, Martin Posch, Ekkehard Glimm, Florian Klinglmueller, Willi Maurer, Kornelius Rohmeyer.   

Abstract

The confirmatory analysis of pre-specified multiple hypotheses has become common in pivotal clinical trials. In the recent past multiple test procedures have been developed that reflect the relative importance of different study objectives, such as fixed sequence, fallback, and gatekeeping procedures. In addition, graphical approaches have been proposed that facilitate the visualization and communication of Bonferroni-based closed test procedures for common multiple test problems, such as comparing several treatments with a control, assessing the benefit of a new drug for more than one endpoint, combined non-inferiority and superiority testing, or testing a treatment at different dose levels in an overall and a subpopulation. In this paper, we focus on extended graphical approaches by dissociating the underlying weighting strategy from the employed test procedure. This allows one to first derive suitable weighting strategies that reflect the given study objectives and subsequently apply appropriate test procedures, such as weighted Bonferroni tests, weighted parametric tests accounting for the correlation between the test statistics, or weighted Simes tests. We illustrate the extended graphical approaches with several examples. In addition, we describe briefly the gMCP package in R, which implements some of the methods described in this paper. 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2011        PMID: 21837623      PMCID: PMC3427907          DOI: 10.1002/bimj.201000239

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  24 in total

1.  Testing non-inferiority and superiority for two endpoints for several treatments with a control.

Authors:  John Lawrence
Journal:  Pharm Stat       Date:  2010-10-15       Impact factor: 1.894

2.  The application of enhanced parallel gatekeeping strategies.

Authors:  Xun Chen; Xiaohui Luo; Tom Capizzi
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

3.  Gatekeeping procedures in dose-response clinical trials based on the Dunnett test.

Authors:  Alex Dmitrienko; Walt Offen; Ouhong Wang; Dan Xiao
Journal:  Pharm Stat       Date:  2006 Jan-Mar       Impact factor: 1.894

4.  Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.

Authors:  Gerhard Hommel; Frank Bretz; Willi Maurer
Journal:  Stat Med       Date:  2007-09-30       Impact factor: 2.373

5.  Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests.

Authors:  Klaus Strassburger; Frank Bretz
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

6.  General multistage gatekeeping procedures.

Authors:  Alex Dmitrienko; Ajit C Tamhane; Brian L Wiens
Journal:  Biom J       Date:  2008-10       Impact factor: 2.207

7.  An efficient method for accommodating potentially underpowered primary endpoints.

Authors:  Jianjun Li; Devan V Mehrotra
Journal:  Stat Med       Date:  2008-11-20       Impact factor: 2.373

8.  Using prior information to allocate significance levels for multiple endpoints.

Authors:  P H Westfall; A Krishen; S S Young
Journal:  Stat Med       Date:  1998-09-30       Impact factor: 2.373

9.  Confidence regions for Bonferroni-based closed tests extended to more general closed tests.

Authors:  Olivier Guilbaud; Par Karlsson
Journal:  J Biopharm Stat       Date:  2011-07       Impact factor: 1.051

10.  Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures.

Authors:  Frank Bretz; Willi Maurer; Gerhard Hommel
Journal:  Stat Med       Date:  2011-02-03       Impact factor: 2.373

View more
  24 in total

1.  Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

Authors:  Jiacheng Yuan; Herbert Pang; Tiejun Tong; Dong Xi; Wenzhao Guo; Peter Mesenbrink
Journal:  J Biopharm Stat       Date:  2015-09-21       Impact factor: 1.051

2.  Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.

Authors:  Julio Rosenstock; Dale Allison; Andreas L Birkenfeld; Thalia Marie Blicher; Srikanth Deenadayalan; Jacob Bonde Jacobsen; Pierre Serusclat; Rafael Violante; Hirotaka Watada; Melanie Davies
Journal:  JAMA       Date:  2019-04-16       Impact factor: 56.272

3.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

4.  Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  José Baselga; Seock-Ah Im; Hiroji Iwata; Javier Cortés; Michele De Laurentiis; Zefei Jiang; Carlos L Arteaga; Walter Jonat; Mark Clemons; Yoshinori Ito; Ahmad Awada; Stephen Chia; Agnieszka Jagiełło-Gruszfeld; Barbara Pistilli; Ling-Ming Tseng; Sara Hurvitz; Norikazu Masuda; Masato Takahashi; Peter Vuylsteke; Soulef Hachemi; Bharani Dharan; Emmanuelle Di Tomaso; Patrick Urban; Cristian Massacesi; Mario Campone
Journal:  Lancet Oncol       Date:  2017-05-30       Impact factor: 41.316

5.  Author's reply: To PMID 21837623.

Authors:  Frank Bretz; Martin Posch; Ekkehard Glimm; Florian Klinglmueller; Willi Maurer; Kornelius Rohmeyer
Journal:  Biom J       Date:  2013-01-16       Impact factor: 2.207

6.  Graphical approaches for the control of generalized error rates.

Authors:  David S Robertson; James M S Wason; Frank Bretz
Journal:  Stat Med       Date:  2020-06-17       Impact factor: 2.373

7.  Adaptive graph-based multiple testing procedures.

Authors:  Florian Klinglmueller; Martin Posch; Franz Koenig
Journal:  Pharm Stat       Date:  2014-10-16       Impact factor: 1.894

8.  A simple and flexible graphical approach for adaptive group-sequential clinical trials.

Authors:  Toshifumi Sugitani; Frank Bretz; Willi Maurer
Journal:  J Biopharm Stat       Date:  2014-11-05       Impact factor: 1.051

9.  MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction.

Authors:  Otília Menyhart; Boglárka Weltz; Balázs Győrffy
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.752

Review 10.  Challenges in the clinical development of PI3K inhibitors.

Authors:  Cristian Massacesi; Emmanuelle di Tomaso; Nathalie Fretault; Samit Hirawat
Journal:  Ann N Y Acad Sci       Date:  2013-03       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.